University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia : A Population-Based Cohort Study

dc.contributor.authorDoherty, Niamh
dc.contributor.authorCardwell, Chris R
dc.contributor.authorMurchie, Peter
dc.contributor.authorHill, Christopher
dc.contributor.authorAzoulay, Laurent
dc.contributor.authorHicks, Blánaid
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2024-01-04T00:16:52Z
dc.date.available2024-01-04T00:16:52Z
dc.date.embargoedUntil2024-01-04
dc.date.issued2023-03-06
dc.descriptionFinancial Support: Dr’s B Hicks and CR Cardwell received funding from Cancer Research UK Population Research Fellowship (grant reference 22185). The funder had no role in the study design, analysis, interpretation or writing of the manuscripten
dc.description.statusPeer revieweden
dc.format.extent7
dc.format.extent341694
dc.identifier226143909
dc.identifier61baabcc-af18-4c8d-97c1-7b44c0a0e864
dc.identifier36634196
dc.identifier85149999405
dc.identifier.citationDoherty, N, Cardwell, C R, Murchie, P, Hill, C, Azoulay, L & Hicks, B 2023, '5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia : A Population-Based Cohort Study', Cancer Epidemiology, Biomarkers and Prevention, vol. 32, no. 3, pp. 428-434. https://doi.org/10.1158/1055-9965.EPI-22-1109en
dc.identifier.doi10.1158/1055-9965.EPI-22-1109
dc.identifier.iss3en
dc.identifier.issn1055-9965
dc.identifier.otherORCID: /0000-0001-9968-5991/work/127817939
dc.identifier.urihttps://hdl.handle.net/2164/22496
dc.identifier.vol32en
dc.language.isoeng
dc.relation.ispartofCancer Epidemiology, Biomarkers and Preventionen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectBenign prostatic hyperplasiaen
dc.subjectkidney canceren
dc.subjectbladder canceren
dc.subject5-alpha reductase inhibitoren
dc.subjectepidemiologyen
dc.subjectR Medicineen
dc.subjectCancer Research UKen
dc.subject22185en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.title5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia : A Population-Based Cohort Studyen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Doherty_etal_CEBP_Alpha_Reductase_Inhibitors_AAM.pdf
Size:
333.69 KB
Format:
Adobe Portable Document Format

Collections